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Abstract Isothermal titration calorimetry (ITC) tech-
nique was used to study the interactions of trypsin with
bicyclic sunflower-derived trypsin inhibitor (SFTI-1) as
well as with its new monocyclic (with disulphide bridge
only) analogues (C3H5O)–SFTI-1 and (C8H15O)–SFTI-1.
ITC measurements were run in 50 mM buffer solution of
HEPES or Tricine of pH 8, containing 20 mM CaCl2 at
298.15 K. Based on calorimetric data, the equilibrium
constants for the inhibitor–enzyme-binding processes, K,
the binding stoichiometry, N (inhibitor-to-enzyme molar
ratio), as well as thermodynamic parameters (DG, DH, DS)
for the reactions were determined. The study revealed that
the stoichiometry of the resulting complexes equals 1:1.
The negative binding enthalpy (DITCH) and favourable
entropy factor (TDITCS) suggest an important contribution
of hydrogen bonding as well as hydrophobic interactions to
the inhibitor–enzyme affinity. Furthermore, the relationship
between the modification of the peptide structure, the
experimental conditions and the thermodynamic parame-
ters has been discussed.
Keywords Isothermal titration calorimetry  Serine
protease inhibitors  Sunflower trypsin inhibitor 1 
Reaction stoichiometry
Introduction
Serine proteases are found ubiquitously in living organisms
and viral genomes [1, 2]. In humans, they play key roles in
many physiological and pathological processes, such as:
digestion (trypsin, chymotrypsin, pancreatic elastase),
blood coagulation (thrombin, coagulation factor Xa), fib-
rinolysis (urokinase, plasmin), immune response (tryptase,
cathepsin G, proteinase 3), type 2 diabetes (dipeptidyl
peptidase IV), respiratory disease (human neutrophil elas-
tase) and cancers [1].
The vast majority of serine proteases have chy-
motrypsin-like or subtilisin-like fold [3]. Their name is
derived from Ser195 (chymotrypsin numbering) residue
found in an enzyme active site. The Ser c-hydroxyl group is
a nucleophile that attacks a carbonyl group of the backbone
of peptidic substrate and forms a tetrahedral intermediate.
This action is facilitated by His57 residue acting here as a
general base. The protonated His57 is stabilized by
hydrogen bond formed with Asp102. All these three amino
acids—Ser, His, Asp—are known as the catalytic triad or
the charge relay system [1]. The acyl-enzyme intermediate
is stabilized additionally by an oxyanion-binding site (also
known as the oxyanion hole) formed by backbone amide
groups of Gly193 and Ser195. Thereafter, the protonated
His57 acting as a general acid transfers a proton to amine
of the intermediate which causes expulsion of the amine
fragment (the first product) as a leaving group. The cova-
lent acyl-enzyme complex is attacked by water molecule,
leading to the formation of a new tetrahedral intermediate
that undergoes a subsequent breakdown. This process is
also assisted by His57. Finally, a second peptide product is
released, and the enzyme Ser195 is regenerated.
Serine proteases catalyse substrate hydrolysis in a highly
selective, efficient and limited manner. Their proteolytic
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activity must be kept under tight control, and this is
achieved at multiple levels: regulated expression and
secretion, controlled activation of inactive pro-enzymes
(zymogens), segregation within organelles (e.g. lyso-
somes), pH regulations as well as reversible or irreversible
inhibition. Therefore, both natural and synthetic inhibitors
of serine proteinase are regarded as a promising class of
therapeutic agents. Some of them have been clinically
approved for the treatment of various diseases [4].
In the course of our ongoing researches on serine pro-
teinase inhibitors, we report here the study on thermody-
namic interactions of trypsin with sunflower-derived
trypsin inhibitor (SFTI-1 [5]) and its new analogues
(C3H5O)–SFTI-1 and (C8H15O)–SFTI-1 (Fig. 1). SFTI-1 is
a backbone-cyclized peptide composed of 14 amino acids
and bisected by one disulphide bridge into binding and
secondary loops. SFTI-1 belongs to the well-characterized
Bowman–Birk family of natural inhibitors and displays
high affinity towards trypsin (based on the independent
colorimetric analyses, the association constant Ka = 1.1 9
1010 M-1 [6] and inhibition constant Ki = 0.1 nM [5],
1 nM [7] and 13 nM [8]). Moreover, we showed that both
native bicyclic SFTI-1 and its analogue deprived of the
cyclic backbone, but having the disulphide bond, have
comparable inhibitory activity [6]. Bowman–Birk inhibi-
tors interact with their cognate enzymes via the standard
mechanism using a common structural motif: a protease-
binding loop [9, 10]. The loop is solvent-exposed, extended
and complementary to the concave enzyme’s active site.
The loop’s central part contains the peptide bond, which is
described as a reactive site P1–P1
0. According to the
Schechter and Berger nomenclature [11], P1–P1
0 is the
scissile peptide bond and both amino acid residues P1 and
P1
0 interact with the corresponding enzyme’s S1 and S10
subsides.
In the current research, we analyse wild-type bicyclic
SFTI-1 and its two analogues comprising the disulphide
bridge only and having their N-terminal ends acylated. The
acylation of a peptide N-terminal end is considered to
provide enhanced stability towards proteolysis by
aminopeptidase. Moreover, such modification makes pep-
tide more hydrophobic which is known to improve cell
permeability as well as may increase their therapeutic
potential [12, 13].
To get better insight into the inhibitor–enzyme interac-
tion, the isothermal titration calorimetry (ITC) technique
was applied to determine the equilibrium constant for the
inhibitor–enzyme-binding process, K, the binding stoi-
chiometry, N (inhibitor-to-enzyme molar ratio), as well as
thermodynamic parameters for the reactions. In particular,
we aimed to investigate how the additional hydrophobic
moieties introduced at the N-terminal end of the disul-
phide-bridged SFTI-1 would affect the inhibitor–enzyme
interactions. The establishment of the enthalpy change
(DH) and entropy change (DS) contributions to the for-
mation of the inhibitor–enzyme complex may be helpful
for the in-depth understanding of the relationship between
the structure of the inhibitor and its physicochemical as
well as biological properties.
Materials and methods
Peptide synthesis
The peptides were synthesized manually via the solid-
phase approach on 2-chlorotrityl chloride resin (Cal-
biochem/Novabiochem) using Fmoc (fluorenyl-9-
methoxycarbonyl) chemistry as was described previously
[14]. The N-terminal ends of (C3H5O)–SFTI-1 and
(C8H15O)–SFTI-1 were acylated with either propionic or
octanoic acid (Sigma-Aldrich) in the presence of equimolar
amount of N,N0-diisopropylcarbodiimide (DIPCI, GL Bio-
chem) and 1-hydroxybenzotriazole (HOBt, GL Biochem)
in dimethylformamide (DMF) for 90 min. Both peptides
were cleaved form the support by a 3-h treatment with a
mixture of trifluoroacetic acid (TFA)/phenol/triisopropyl-
silane/H2O (88:5:2:5, v/v/v/v). Under these conditions, all
protecting groups were removed. In the case of wild-type
SFTI-1, after completing the synthesis, the peptide was
cleaved from the resin using a mixture of acetic acid/2,2,2-
trifluoroethanol/methylene chloride (2:2:6, v/v/v) for 1.5 h
at room temperature. Under these conditions, the cleaved







Fig. 1 Chemical formulas of wild-type SFTI-1 and its two acylated
analogues with disulphide bridges only. Solid lines denote covalent
bonds between either amino acids or sulfhydryl groups. The P1–P1
0
reactive site is located between Lys5 and Ser6 residues. (C3H5O) and
(C8H15O)—propanoyl and octanoyl groups, respectively
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next step, the head-to-tail cyclization of SFTI-1 was per-
formed using benzotriazolyloxy-tris[pyrrolidino]-phospho-
nium hexafluorophosphate (PyBop)/N,N-diisopropy-
lethylamine (molar ratio 1:2) in DMF. Next, all protecting
groups were removed using TFA/phenol/triisopropylsilane/
H2O (88:5:2:5, v/v/v/v). Disulphide bond formation was
performed using the 0.1 M iodine solution in methanol.
The peptide purity was checked by a reverse-phase high-
performance liquid chromatography (RP-HPLC) on a
Shimadzu Prominence UFLC equipped with a Supelco
Supelcosil column (250 9 4.6 mm, 5 lm, C-8, Supelco/
Sigma-Aldrich) and a UV–Vis detector. The solvent sys-
tem was 0.1 % TFA (A) and 80 % acetonitrile in 0.1 %
TFA (B). A linear gradient from 10 to 90 % B within
30 min, with a flow rate of 1.0 mL min-1 and monitoring
set at 226 nm, was applied. The crude peptides were
purified by RP-HPLC on a Beckman Gold System (Beck-
man) using a semi-preparative Discovery BIO Wide Pore
column C-8 (250 9 10 mm, 5 lm, Supelco/Sigma-
Aldrich). The solvent system was 0.1 % TFA (A) and 80 %
acetonitrile in A (B). The mass spectrometry analysis of the
synthesized compounds was carried out on MALDI MS
(Biflex III MALDI-TOF spectrometer, Bruker Daltonics)
using an a-cyano-4-hydroxycinnamic acid (CCA) and/or
2,5-dihydroxybenzoic acid (DHB) matrix.
Determination of trypsin and wild-type SFTI-1
concentrations
Bovine b-trypsin and a trypsin burst substrate nitrophenyl-
40-guanidinobenzoate (NPGB) were purchased from
Sigma-Aldrich. All colorimetric measurements were per-
formed using Cary 3E Spectrophotometer (Varian). Bovine
b-trypsin solution was prepared by dissolving approxi-
mately 7 mg of the lyophilized trypsin in 1 mL of 1 mM
HCl containing 20 mM CaCl2. The stock solution of
bovine b-trypsin was standardized with NPGB according to
Chase and Shaw method [15]. The standardized trypsin
solution was used to titrate wild-type SFTI-1.
Determination of the acylated SFTI-1 analogues
concentrations
The molar concentration of each peptide was determined
using HPLC method as described previously [16]. Peptides
were dissolved in either 50 mM Tricine (pH 8.0) or 50 mM
HEPES (pH 8.0) buffers containing 20 mM CaCl2 at
concentrations of about 4 mg mL-1. Equal volume of each
solution was injected into the HPLC column. The peptide
peak area was integrated and compared to that of the
standardized wild-type SFTI-1.
Isothermal titration calorimetry (ITC)
All ITC experiments were performed at 298.15 K using an
Auto-ITC isothermal titration calorimeter (MicroCal Inc.,
GE Healthcare, Northampton, USA) with a 1.4491 mL
sample and reference cells. The reference cell contained
the distilled water. All details of the measuring devices and
the experimental set-up were described previously [17–19].
All reagents were dissolved directly into 50 mM buffer
solution of HEPES or Tricine of pH 8.0, containing 20 mM
CaCl2. The experiment consisted of injecting 10.02 lL
(29 injections, 2 lL for the first injection only) of
0.23–0.27 mM buffered solution of an appropriate peptide
into the reaction cell initially containing buffered solution
of 0.019 mM trypsin.
A background titration, consisting of an identical titrant
solution but with the buffer solution in the reaction cell
only, was removed from each experimental titration to
account for the heat of dilution. All the solutions were
degassed prior to the titration. The titrant was injected at
5-min intervals to ensure that the titration peak returned to
the baseline before the next injection. Each injection lasted
20 s. For the sake of homogeneous mixing in the cell, the
stirrer speed was kept constant at 300 rpm. A calibration of
the Auto-ITC calorimeter was carried out electrically by
using electrically generated heat pulses. The CaCl2–EDTA
titration was performed to ensure that the apparatus was
working correctly, and the results (N-stoichiometry, K, DH)
were compared with those obtained from the same samples
(a test kit) at MicroCal Inc., Malvern.
Results and discussion
The stability constants (KITC) and binding enthalpies
(DITCH) of interactions of the inhibitors with bovine b-
trypsin were obtained from ITC experiments by fitting
isotherms (using nonlinear least-squares procedures) to a
model that assumes a single set of identical binding sites.
These thermodynamic parameters (KITC, DITCH) depend on
the condition under which the ITC experiments were per-
formed (i.e. temperature, pH as well as the kind of the
buffer solution). Thus, the obtained data are considered as
condition-dependent parameters. Then, the conditional free
energy of binding (DITCG) and entropy change (DITCS)
were calculated using the standard thermodynamic rela-
tionships: DITCG = -RTlnKITC = DITCH - TDITCS. The
results are collected in Table 1. Representative binding
isotherms for interactions of the peptide tested (SFTI-1 and
its acylated analogues) with trypsin are shown in Figs. 2
and 3.
The isothermal titration calorimetric data confirmed the
prior knowledge [5, 20] that the stoichiometry of the
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resulting inhibitor–trypsin complexes equals 1:1 (SFTI-1/
enzyme). The fully exposed binding loop of the bicyclic
SFTI-1 possesses only one P1–P1
0 reactive site with Lys
residue in the P1 position that is mainly responsible for
interactions with the enzyme. It was shown by
Luckett et al. [5] that Lys projects into the deep S1 sub-
strate pocket of the enzyme and makes either direct or
water-mediated interactions with Ser190 and Asp189
residues found at the base of this pocket.
The data collected in Table 1 show that the thermody-
namic stability of the inhibitor–enzyme complexes is
comparable to each other. The change in free energy of
binding (DITCG = -RTlnKITC) for all the systems remains
the same in the range of the experimental error. Thus, both
modifications—the absence of cyclic backbone and the
presence of the N-terminal hydrophobic moieties with
various lengths (either propanoyl or octanoyl, Fig. 1)—do
not affect the stability of the complexes studied. Further-
more, based on the DITCH and TDITCS values (Table 1), it
can be concluded that the formation of the complexes is
both enthalpy- and entropy-driven processes. Thus, the
binding of the inhibitor to enzyme is comprised of hydro-
gen bonding and hydrophobic interactions as indicated by
the negative binding enthalpy (DITCH) and favourable
entropy factor (TDITCS). This finding is consistent with the
data acquired from the crystallographic study [5] which
showed that the interaction between native SFTI-1 and
trypsin is stabilized by an extensive network of hydrogen
Table 1 Thermodynamic parameters of the inhibitor tested binding to trypsin in buffer solutions (HEPES and Tricine) of pH 8.0, at 298.15 K
Buffer Log K DITCG/kcal mol-1 DITCH/kcal mol-1 TDITCS/kcal mol-1 Stoichiometry
SFTI-1
HEPES 7.88 (±0.22) -10.75 (±0.25) -5.45 (±0.07) 5.30 (±0.26) 0.84 (±0.01)
Tricine 8.13 (±0.22) -11.09 (±0.25) -5.83 (±0.07) 5.26 (±0.26) 0.84 (±0.01)
(C3H5O)–SFTI-1
HEPES 8.17 (±0.37) -11.15 (±0.50) -5.64 (±0.03) 5.51 (±0.50) 0.91 (±0.01)
Tricine 8.20 (±0.58) -11.19 (±0.78) -5.61 (±0.06) 5.58 (±0.78) 0.90 (±0.01)
(C8H15O)–SFTI-1
HEPES 7.71 (±0.20) -10.52 (±0.29) -4.95 (±0.03) 5.57 (±0.29) 0.92 (±0.01)
Tricine 8.08 (±0.26) -11.02 (±0.35) -5.20 (±0.03) 5.82 (±0.35) 0.87 (±0.01)




















































































Fig. 2 Calorimetric titration isotherms of the binding interaction between inhibitor [SFTI-1, (C3H5O)–SFTI-1 and (C8H15O)–SFTI-1] and
enzyme (trypsin) in 50 mM HEPES (20 mM CaCl2) of pH 8.0, at 298.15 K
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bonds and ion pairs. On the other hand, the entropic gain
may also arise from the desolvation upon the interaction of
the solvent-exposed peptide loop with the concave tryp-
sin’s active site. To assess the influence of experimental
conditions on thermodynamic parameters (DITCH and
DITCS), the ITC experiments were carried out in buffer
solutions of the same pH, but different enthalpies of proton
association with the buffer’s component (DBHH). This
approach has been applied earlier to several protein sys-
tems including aspartic protease [21], stromelysin-1 [22]
and HIV-1 protease [23] to dissect protonation contribu-
tions from binding. The enthalpy measured in the ITC
experiment, DITCH, is the sum of all energetic effects
accompanying the reaction, i.e. the enthalpy due to the heat
of complex formation, DbindH, which is independent of the
kind of buffer, and the energy due to proton transfer from
the reagent to the buffer [24–26]. For a given pH, the
relationship between DITCH and the enthalpy of buffer
ionization DBHH (BH
± = B- ? H?) is a straight line
whose slope corresponds to the number of protons
(Dn) interchanged during the reaction: DITCH = Dbind-
H ? (Dn)DBHH. The ionization energies of the buffers
used in this study are 4.9 and 7.5 kcal mol-1 for HEPES
and Tricine, respectively [27]. As seen in Table 1, the
measured binding enthalpies, DITCH, are not dependent
upon the ionization enthalpy of the buffer system in which
the reaction was conducted (Dn & 0). Thus, it is highly
probable that the inhibitor–trypsin interactions are not
accompanied by a change in protonation of the reagents.
For this reason, it can be supposed that the interaction
studied will not be dependent upon the ionization enthalpy
of the buffer used (DITCH & DbindH) [28].
Conclusions
The ITC technique has successfully been applied to
determine the stoichiometry, binding constants (K) and
thermodynamic parameters (DG, DH, DS) for interactions
of trypsin with sunflower-derived trypsin inhibitor (SFTI-
1) as well as with its new monocyclic analogues (C3H5O)–
SFTI-1 and (C8H15O)–SFTI-1. It has been found that the
stoichiometry of the inhibitor–enzyme complexes equals
1:1, and their stability is governed by hydrogen bonding as
well as hydrophobic interactions. Carrying out the mea-
surements in buffer solutions of equal pH but different
enthalpies of ionization of its components (HEPES, Tri-
cine) revealed that the inhibitor–trypsin interactions are not
accompanied by proton transfer from the reagent to the
buffer. Furthermore, it has been proved that the presence of
the hydrophobic group, either propanoyl or octanoyl, at the
N-terminal end of monocyclic SFTI-1 [for (C3H5O)–SFTI-1
and (C8H15O)–SFTI-1, respectively] does not affect inter-
actions with trypsin. Thus, it can be supposed that the
N-terminal end of SFTI-1 can be acylated to obtain com-
pounds with better pharmacokinetics properties.





















































































Fig. 3 Calorimetric titration isotherms of the binding interaction between inhibitor [SFTI-1, (C3H5O)–SFTI-1 and (C8H15O)–SFTI-1] and
enzyme (trypsin) in 50 mM Tricine (20 mM CaCl2) of pH 8.0, at 298.15 K
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